RxDoctor Payments Data

Madeline Beld, NP

Family · Hudsonville, MINPI 1578178398

Payments from drug & device makers

$1,590in general payments, 2019–2025

Across 97 payments — averaging $16.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$507
  • Boehringer Ingelheim$272
  • Biohaven Pharmaceutical Holding Company Ltd.$120
  • Novo Nordisk$94
  • AstraZeneca$80
  • Lilly USA, LLC$78
  • plus $439 from 15 others

What the payments were for

  • Food & beverage$1,590100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,590 in reported general payments places this provider in the 75th percentile of 3,657 family providers in Michigan.

See all family providers in Michigan

Medicare billing

Part B allowed, 2024
$3,498
Medicare patients
27
Services billed
52

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban29$19,469
TrulicityDulaglutide20$19,084
JardianceEmpagliflozin12$9,575
JanuviaSitagliptin Phosphate13$7,614
FarxigaDapagliflozin Propanediol11$7,614
MyrbetriqMirabegron14$6,620
XareltoRivaroxaban12$6,291
Lantus SolostarInsulin Glargine,hum.Rec.Anlog49$1,983
Rosuvastatin Calcium47$1,760
Atorvastatin Calcium73$1,496
Metoprolol Succinate56$1,466
Valproic AcidValproic Acid (As Sodium Salt)12$1,141
Quetiapine Fumarate37$837
Levetiracetam13$716
Albuterol Sulfate HfaAlbuterol Sulfate24$670

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$26$19,46929 claims
Lilly USA, LLCTrulicity$78$19,08420 claims
Boehringer IngelheimJardiance$272$9,57512 claims
AstraZenecaFarxiga$80$7,61411 claims
Johnson & JohnsonXarelto$12$6,29112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,657 family providers in Michigan.

Other family in Hudsonville

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →